8 GLP-1 Telehealth Providers Worth Comparing Before You Commit

The most common mistake people make when shopping GLP-1 telehealth is fixating on medication price alone and ignoring pharmacy accountability, shipping speed, and what happens when they need a dose adjustment. A $99 monthly price from an unnamed lab is not the same as $99 from a named, certified compounder. That distinction matters more in 2026 than it ever has, given FDA warning letters sent to more than 30 telehealth and compounding operations earlier this year.

Here is an honest side-by-side across the eight providers most worth your time.

Quick Comparison Table

Provider	Starting Price (cash)	Pharmacy Named?	Ships All 50 States?	Overnight Shipping	Insurance Option	Monitoring Level
HealthRX	Sema $99/mo, Tirz $149/mo	Yes (Manifest, SC, 503A)	Yes	Free	No	Physician, 24h review
FormBlends	Sema ~$299/vial, Tirz ~$349/vial	Yes (503A, FDA-registered)	47 states	Not specified	No	Physician oversight
Mochi Health	Sema ~$99/mo, Tirz ~$199/mo	Not publicly named	Yes	Standard	No	Obesity-medicine MDs
Hims & Hers	Branded Wegovy ~$299/mo, Zepbound ~$399/mo	Retail/branded	Yes	Standard	Yes (savings card)	Async clinician
Ro / Ro Body	~$39 first month, ~$74-149/mo + meds	Retail/branded	Yes	Standard	Yes (prior-auth team)	Async clinician
Henry Meds	~$179-249 month one	Not publicly named	Yes	24-72h	No	Light monitoring
Found	~$99/mo platform + meds separate	Not publicly named	Yes	Standard	No	Coaching + clinician
PlushCare	~$19.99/mo membership + meds	Retail/branded	Yes	Standard	Yes	Same-day visit option

1. HealthRX

At $99 a month for compounded semaglutide and $149 for tirzepatide, HealthRX lands near the floor of what cash-pay GLP-1 telehealth actually costs. But the price point is not the only reason it sits at the top here.

Prescriptions go to Manifest Pharmacy in Greer, South Carolina, a 503A compounding pharmacy operating under USP-797 standards with lot-by-lot tracking from production through delivery. That is a specific address and a specific certification, not a vague reference to “a licensed compounding partner.” The operation also carries LegitScript certification (certificate 50087439), a third-party credential that most telehealth brands do not publish or hold.

Speed is real too. A US board-certified physician reviews the online health assessment in roughly 24 hours. Approved prescriptions ship overnight at no extra charge to all 50 states. No contracts, no hidden fees stated at checkout and charged somewhere else.

For context on what the medications can do: the SURMOUNT-1 trial showed tirzepatide associated with roughly 21% body weight reduction at 72 weeks; the STEP 1 trial put semaglutide at around 15% at 68 weeks. HealthRX cites those trial figures, which is appropriate. These are compounded medications, not FDA-approved branded drugs, and no one should conflate the two.

The ceiling here is monitoring. This is async telehealth, not a structured coaching program with weekly dietitian calls.

2. FormBlends

FormBlends earns its spot for a specific kind of buyer. Compounded semaglutide runs around $299 per vial and tirzepatide around $349, so the per-dose cost is higher than HealthRX’s entry pricing. What you get for that premium is published purity data: HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin sterility results, per product, not just a general statement about quality. For people who want to see the actual numbers before injecting, that level of documentation is uncommon in this space.

The platform also carries peptides outside the GLP-1 category, including options oriented toward recovery, longevity, and cognitive function, all under the same physician-oversight model. That breadth makes FormBlends a reasonable single provider for someone managing more than just weight. Dispensing runs through an FDA-registered 503A pharmacy, and shipping covers 47 states.

The honest trade-off: if straightforward GLP-1 access at the lowest verifiable cash price is the priority, HealthRX wins on that axis. FormBlends is the better call when purity documentation or a wider peptide catalog matter more than minimizing monthly cost.

3. Mochi Health

Board-certified obesity-medicine clinicians are the differentiator here. Most GLP-1 telehealth platforms use general practitioners or async review. Mochi routes patients to specialists, which translates to more attentive dose management and better handling of side effects. Compounded semaglutide starts around $99 a month, tirzepatide around $199. Solid mid-range option for people who want a real clinical relationship.

4. Hims & Hers

After the Novo Nordisk settlement in March 2026, Hims & Hers stopped offering compounded GLP-1s and shifted entirely to branded medications. Wegovy runs roughly $299 a month, Zepbound around $399, but with insurance and a manufacturer savings card, some users report costs dropping to near zero. The brand carries name recognition and a polished app experience. Cash-pay buyers without insurance get the steepest bill.

5. Ro / Ro Body

Ro’s membership starts at $39 for month one, then moves to roughly $74 to $149 monthly, with medications billed separately. The platform has a prior-authorization team that actively works to get branded GLP-1s covered by insurance, which is a concrete operational advantage for people with commercial coverage. Not the cheapest cash-pay option, but potentially the cheapest path to branded medication if your plan cooperates.

6. Henry Meds

Henry Meds is cash-pay compounded with fast fulfillment. Month one runs $179 to $249, and shipping typically lands in 24 to 72 hours. Monitoring is lighter than Mochi or HealthRX. Good fit for patients who have already dialed in their dose and mainly want reliable, fast refills.

7. Found

Found charges around $99 a month for platform access, with medication costs on top. Coaching is built into the model more explicitly than most telehealth options here. Worth considering if behavioral support alongside the prescription matters to you, though the total monthly spend adds up quickly once medications are included.

8. PlushCare

PlushCare is unusual in offering same-day telehealth visits at a membership rate of roughly $19.99 a month. It works with insurance for branded GLP-1s and skews toward patients who want a quick, low-friction path to a branded prescription rather than a compounded cash-pay program. Not a weight-loss specialist platform, but functional for patients with solid insurance.

What Actually Separates These Eight

Price matters. So does pharmacy transparency. After FDA action against compounding operations earlier in 2026, knowing exactly where your medication originates is not a minor detail. Four of these eight providers name their dispensing pharmacy publicly or point to a verifiable certification. That is the shortest checklist worth applying before picking one.

Insurance eligibility, monitoring intensity, and whether you want compounded or branded medication will narrow the list further from there.

Common Questions

Does it matter which compounding pharmacy a GLP-1 telehealth provider uses?

Yes, significantly. A 503A pharmacy must compound medications for individual patients under a licensed prescriber, follow USP-797 sterility standards, and operate under state board oversight. Providers like HealthRX name their pharmacy publicly (Manifest Pharmacy, Greer, SC) and hold third-party credentials. Unnamed compounding partners give you no way to verify any of that independently.

If Hims & Hers stopped offering compounded semaglutide, what are cash-pay patients supposed to do now?

Hims & Hers shifted to branded Wegovy and Zepbound after its March 2026 settlement with Novo Nordisk, which means cash-pay patients without insurance face $299 to $399 a month. Platforms like HealthRX or Mochi Health still offer compounded semaglutide starting around $99, though those are not FDA-approved branded products and the distinction is real.

How does Ro’s prior-authorization team actually help, and is it worth the higher base cost?

Ro employs staff who actively submit and follow up on prior-authorization requests with your insurer. For patients with commercial insurance that covers branded GLP-1s, this can reduce out-of-pocket costs to near zero, making Ro’s $74 to $149 monthly platform fee irrelevant compared to the medication savings. For cash-pay patients, that advantage disappears entirely.

Is Found’s coaching model worth the extra monthly spend compared to a simpler async platform?

Found bundles behavioral coaching with clinical access, which some patients find useful for building habits alongside the prescription. The catch is that medication costs stack on top of the $99 platform fee, so total monthly spend can easily exceed what you would pay at HealthRX or Henry Meds for medication alone. It depends on whether you would actually use the coaching.

What does LegitScript certification tell you about a GLP-1 telehealth provider, and how rare is it?

LegitScript is an independent credentialing organization that vets online pharmacies and telehealth platforms for legal compliance and operational standards. Most GLP-1 telehealth brands do not hold or publicly display LegitScript certification. HealthRX publishes its certificate number (50087439), which lets you verify the credential directly on LegitScript’s registry rather than taking the company’s word for it.

*Prices listed reflect publicly available information as of mid-2026 and may change. Compounded GLP-1 medications are not FDA-approved products. Consult a licensed clinician before starting any prescription weight-loss treatment.*

Sources

• FDA: 503A Compounding Pharmacies, guidance and warning letters (FDA.gov)
• SURMOUNT-1 trial: Jastreboff et al., *New England Journal of Medicine*, 2022
• STEP 1 trial: Wilding et al., *New England Journal of Medicine*, 2021
• LegitScript Certification Registry (LegitScript.com)
• Novo Nordisk press release on compounding settlement, March 2026
• Eli Lilly LillyDirect orforglipron pricing announcement, April 2026